4202 articles
US comedienne Kate Flannery has partnered with the Contact Lens Institute (CLI) to encourage eyecare professionals to consider the EASY Way when discussing healthy wear-and-care routines with soft con
London’s Moorfields Eye Hospital pitted consultant ophthalmologists against their more junior colleagues to compare immediate sequential bilateral cataract surgeries (ISBCS) outcomes over three years to better understand the relationship between the grade of surgeon and ISBCS outcomes.
Having completed New Zealand's 3,026km Te Araroa Trail in 2023 to raise funds for his charity Eye Care for Africa, Hawke’s Bay optometrist Niall McCormack is at it again. This time, he is walking the length of the UK to raise more funds for Eye Care for Africa and Glaucoma New Zealand (GNZ).
A group of researchers in China has recommended people at high risk of AMD avoid instant coffee.
Researchers at the University of Adelaide found that intravitreal use of the bevacizumab biosimilar MVASI has a similar ophthalmic safety profile and may be used as an alternative to Avastin. Alth
A UK study found visual processing speed can predict dementia risk 12 years before diagnosis by conventional assessment. Researchers at Loughborough University and Cambridge University conducted
A UK survey found patients and their relatives were overwhelmingly in favour of using artificial intelligence (AI) in diagnostic testing of inherited retinal diseases (IRDs) to accelerate genetic diag
Researchers in the US and Brazil have found that a cheap oral inflammasome inhibitor, commonly prescribed for patients with HIV, significantly improved vision in patients with centre-involved diabetic
US genetic med-tech company Krystal Biotech announced it had dosed its first patient in the IOLITE Phase 3 Study of KB803, a re-dosable eye drop gene therapy designed to treat and prevent corneal abra
US researchers found cannabis use moderately lowered the risk of proliferative vitreoretinopathy (PVR) development in patients who underwent retinal detachment (RD) repair.
A team of international researchers found artificially increasing levels of apolipoprotein M (ApoM), a natural protein involved in cholesterol metabolism, improved retinal pigment epithelium (RPE) function in mice with age-related macular degeneration (AMD).
Returning to the largest agricultural event in the Southern Hemisphere, Macular Degeneration New Zealand (MDNZ) delivered 345 OCT scans and had lots of conversations about the importance of eye-health checks at Fieldays in Mystery Creek, Hamilton.
